Evaluation of tartrate-resistant acid phosphatase (TRACP) 5b as bone resorption marker in irradiated bone metastases

Anticancer Research

Volumn 25, Issue 6 C, 2005, Pages 4639-4645

  Mose, Stephan ^a,c   Menzel, Christian ^a   Kurth, Andreas A ^a   Obert, Kirstin ^a   Ramm, Ulla ^a   Eberlein, Klaus ^a   Boettcher, Heinz D ^a   Pichlmeier, Uwe ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c SCHWARZWALD BAAR KLINIKUM   (Germany)

Author keywords

Bone metastases; Breast cancer; Radiotherapy; TRACP 5b

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY O1A; TARTRATE RESISTANT ACID PHOSPHATASE 5B; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOLID; TIME;

ACID PHOSPHATASE; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BONE RESORPTION; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; ISOENZYMES; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PAIN; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 28444463977     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Koswig S, Buchali A, Boehmer D, Schienger L and Budach V: Palliative radiotherapy of bone metastases. A retrospective analysis of 176 patients. Strahlenther Onkol 175: 509-514, 1999.
2. Plebani M, Bernardi D, Zaninotto M, De Paoli M, Secchiero S and Sciacovelli L: New and traditional serum markers of bone metabolism in the detection of skeletal metatases. Clin Biochem 29: 67-72, 1996
3. Seibel MJ and Woitge HW: Biochemical markers of bone metabolism - Update 1999. Clin Lab 45: 237-256, 1999
4. Seregni E, Martinetti A, Ferrari L and Bombardieri E: Clinical utility of biochemical marker of bone remodelling in patients with bone metastases of solid tumors. Q J Nucl Med 45: 7-17, 2001.
5. Mose S, Menzel C, Kurth AA, Obert K, Breidert I, Borowsky K and Boettcher HD: Tartrate-resistant acid phosphatase 5b as serum marker of bone metabolism in cancer patients. Anticancer Res 23: 2783-2788, 2003.
6. Halleen JM, Alatalo SL, Suominen H, Cheng S, Janckila AJ and Väänänen HK: Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption. J Bone Miner Res 15: 1337-1345, 2000.
7. Nakanishi M, Yoh K, Miura T, Ohasi T, Rai SK and Uchida K: Development of a kinetic assay for band 5b tartrate-resistant acid phosphatase activity in serum. Clin Chem 46: 469-473, 2000.
8. Alatalo SL, Halleen JM, Hentunen TA, Mönkkönen J and Väänänen HK: Rapid screening method for osteoclast differentiation in vitro that measures tartrate-resistant acid phosphatase 5b activity secreted into culture medium. Clin Chem 46: 1751-1754, 2000.
9. Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel M and Väänänen HK: Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem 47: 597-600, 2001.
10. Janckila AJ, Takahashi K, Sun SZ and Yam LT: Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem 47: 74-80, 2001.
11. Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S and Väänänen HK: Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 71: 20-25, 2002.
12. Janckila AJ, Neustadt DH, Nakasato YR, Halleen JM, Hentunen T and Yam LT: Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clinica Chimica Acta 320: 49-58, 2002.
13. Igarashi Y, Lee MY and Matsuzaki S: Acid phosphatases as markers of bone metabolism. J Chromatography B 781: 345-358, 2002.
14. Scarnecchia L, Minisola S, Pacitti MT, Carnevale V, Romagnoli E, Rosso R and Mazzuoli GF: Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 51: 517-524, 1991.
15. Wada N, Ishii S, Ikeda T, Enomoto K and Kitajima M: Serum tartrate-resistant acid phosphatase as a potential marker of bone metastases from breast cancer. Anticancer Res 19: 4515-4522, 1999.
16. Halleen JM, Hentunen TA, Hellman J and Väänänen HK: Human bone tartrate-resistant acid phosphatase: purification and development of an immunoassay. J Bone Miner Res 11: 1444-1452, 1996.
17. Halleen JM, Hentunen TA, Karp M, Käkönen SM, Petterson K and Väänänen HK: Characterization of serum tartrate-resistant acid phosphatase and development of a direct two-site immunoassay. J Bone Miner Res 13: 683-687, 1998.
18. Janckila AJ, Nakasato YR, Neustadt DN and Yam LT: Disease-specific expression of tartrate-resistant acid phosphatase isoforms. J Bone Miner Res 18: 1916-1919, 2003.
19. Halleen JM, Karp M, Viloma S, Laakson P, Hellman J, Käkönen SM, Stehan JJ, Holmes SD, Väänänen HK and Petterson K: Two-site immunoassays for osteoclastic tartrate-resistant acid phosphatase based on characterization of six monoclonal antibodies. J Bone Miner Res 14: 464-469, 1999.
20. Halleen JM: Tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Anticancer Res 23: 1027-1030, 2003.
21. Hannon RA, Clowes JA, Eagleton AC, Al Hadari AA, Eastell R and Blumsohn A: Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoforms 5b as a marker of bone resorption. Bone 34: 187-194, 2004.
22. DeLong ER, DeLong DM and Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44: 837-845, 1988.
23. Chao TY, Ho CL, Lee SH, Chen MMJ, Janckila AJ and Yam LT: Tartrate-resistant acid phosphatase 5b as a serum marker of bone metastasis in breast cancer patients. J Biomed Sci 11: 511-516, 2004.
24. Hoskin PJ: Radiotherapy in the management of bone metastases. In: Bone Metastases - Diagnosis and Treatment. Rubens RD, Fogelman I (eds.). London, Springer Verlag, pp. 171-185, 1991.
25. Koizumi M, Takahashi S1991 Ogata E: Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis. Anticancer Res 23: 4095-4100, 2003.
26. Rankin S: Radiology. In: Bone Metastases - Diagnosis and Treatment. Rubens RD, Fogelman I (eds.). London, Springer Verlag, pp. 63-81, 1991.
27. Capeller B, Caffier H, Sütterlin MW and Dietl J: Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer. Anticancer Res 23: 1011-1016, 2003.
28. Terpos E, De La Fuente J, Szydlo R, Hatjiharissi E, Viniou N, Meletis J, Yataganas X, Goldman JM and Rahemtulla A: Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker of monitoring bone disease in multiple myeloma. Int J Cancer 106: 455-457, 2003.